Paradeep Phosphates LtdQ4 FY24

Paradeep Phosphates Ltd Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹139.79P/E: 13.4Market Cap: ₹14.6K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Sales volumes are expected to depend on the Kharif season progress and the viability of fertilizer grades, especially N10 and N12.
  • Full capacity sales of 3 million tons in FY25 are uncertain; expected utilization is around 2.5 to 3 million tons (25-30 lakh tons) based on market conditions.
  • The company is deepening its footprint in Bihar, UP, Karnataka, and opening markets in Rajasthan.
  • Primary sales of DAP and NPK grew 47% year-on-year with POS volumes reaching 24.77 lakh metric tons.
  • Introduction and ramp-up of bio-nano products (Nano urea and Nano DAP) with a target to reach 1 million units initially.
  • Overall production grew 13% year-on-year with sales increasing by 25%.
  • Market share in DAP and NPK consumption grew by 3% to approximately 9.4%.
  • Revenue growth supported by higher capacity utilization, expanded reach, and new product development.

See what Paradeep Phosphates Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • Paradeep Phosphates is currently executing a major CAPEX project for a sulphuric acid plant, with a project budget of about Rs. 250 crores for FY25.
  • The debt tie-up for this project is already in place, and drawdowns of long-term debt are planned based on project progress.
  • The company does not intend to increase its overall debt levels beyond the committed amounts for this project.
  • Any additional project-related debt will only be drawn down corresponding to necessary expansions, with an aim to avoid fresh debt beyond current commitments.
  • There is no mention of fundraising through equity in the call.
  • The company remains focused on reducing overall debt year-on-year and prudent financial management.

See what Paradeep Phosphates Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Ongoing major CAPEX: Expansion of sulphuric acid capacity at Paradeep site from 1.4 million tons to 2 million tons, expected to be commissioned by end of FY2025.
  • Current CAPEX budget for FY25: Approximately Rs. 250 crores, largely for the approved sulphuric acid project.
  • No plan to increase overall debt levels beyond current commitments; any future debt drawdowns will only be for approved projects.
  • Future backward integration to be discussed post MCFL merger conclusion.
  • Exploration of phosphoric acid plant setup on western coast of India will be addressed after the MCFL merger.
  • Launch of indigenously researched bio-nano fertilizers (nano urea and nano DAP) with good capacity (up to 3.5 million units) and planned ramp-up based on market acceptance.

Track Paradeep Phosphates Ltd — get its next earnings analysis in your feed

How does Paradeep Phosphates Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature
ThisParadeep Phosphates Ltd
Rev 3Mar 3

How does Paradeep Phosphates Ltd rank in Fertilizers & Agrochemicals?

Compare Paradeep Phosphates Ltd against every Fertilizers & Agrochemicals company (Q4 FY24) on revenue, margins and earnings-call signals.

View Fertilizers & Agrochemicals leaderboard →

Others in Fertilizers & Agrochemicals this season

  • Dhanuka Agritech Ltd (Q2 FY27)

    657.51 Crores . Key investor presentation takeaways from Dhanuka Agritech Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.

  • Sharda Cropchem Ltd (Q2 FY27)

    1,051.7 Cr, up 13% YoY (Q2 FY26: Rs. Key investor presentation takeaways from Sharda Cropchem Ltd's Q2 FY27 investor presentation — and how it ranks against sec

  • Astec Lifescienc (Q2 FY27)

    2.3% YoY decline. Key results statement takeaways from Astec Lifescienc's Q2 FY27 results statement — and how it ranks against sector peers.

  • Sumitomo Chemical India Ltd (Q2 FY27)

    907 crore, down 2% YoY (Q2FY26 revenue was Rs. Key investor presentation takeaways from Sumitomo Chemical India Ltd's Q2 FY27 investor presentation — and how it

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →